Viagene Overview

  • Year Founded
  • 1987

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $95M

Viagene General Information

Description

Provider of gene manipulation technology for the discovery of anti-infective therapies. The company's gene manipulation technology uses applied proprietary gene transfer technology to develop drugs that allowed therapeutic proteins to be produced directly inside cells.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11055 Roselle Street
  • San Diego, CA 92121
  • United States
+1 (619)
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 11055 Roselle Street
  • San Diego, CA 92121
  • United States
+1 (619)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Viagene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 25-Apr-1995 $95M Completed Generating Revenue
3. IPO 01-Nov-1993 Completed Generating Revenue
2. Later Stage VC (Series D) 09-Sep-1991 $7M $8M Completed Generating Revenue
1. Early Stage VC 09-Dec-1987 $1M $1M Completed Product Development
To view Viagene’s complete valuation and funding history, request access »

Viagene Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
3i Group PE/Buyout Minority
Chancellor Capital Management Venture Capital Minority
Domain Associates Venture Capital Minority
Fairfield Ventures Venture Capital Minority
Sorrento Associates Corporate Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Viagene FAQs

  • When was Viagene founded?

    Viagene was founded in 1987.

  • Where is Viagene headquartered?

    Viagene is headquartered in San Diego, CA.

  • What industry is Viagene in?

    Viagene’s primary industry is Biotechnology.

  • Is Viagene a private or public company?

    Viagene is a Private company.

  • What is the current valuation of Viagene?

    The current valuation of Viagene is .

  • What is Viagene’s current revenue?

    The current revenue for Viagene is .

  • How much funding has Viagene raised over time?

    Viagene has raised $26M.

  • Who are Viagene’s investors?

    3i Group, Chancellor Capital Management, Domain Associates, Fairfield Ventures, and Sorrento Associates are 5 of 6 investors who have invested in Viagene.

  • When was Viagene acquired?

    Viagene was acquired on 25-Apr-1995.

  • Who acquired Viagene?

    Viagene was acquired by Chiron (Biotechnology).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process